Safety of 48 months of elagolix with add-back therapy for endometriosis-associated pain
{{output}}
Background: Elagolix (ELA) 200 mg twice daily is an oral treatment approved for moderate-to-severe endometriosis-associated pain. However, the clinical use of ELA is limited by potential hypoestrogenic effects, including the loss... ...
